Mesenchymal stem/stromal cells (MSCs) are principal components of an important endogenous repair system that allows constant self-renewal of adult tissues in many organs. MSCs were first described in 1970 as colony forming units fibroblasts 1 and can be isolated from various tissues, including bone marrow, adipose tissue, umbilical cord blood, and peripheral blood. Although MSC populations have been characterized by different sets of markers, specific consensus criteria have been defined to identify MSCs, including adherence to plastic in standard culture conditions, expression of common MSC cell surface markers (e.g. CD73, CD90, and CD105), and capacity for trilineage differentiation into osteoblasts, adipocytes, and chondrocytes in cell culture 2 . In addition to their ability to migrate and differentiate into multiple cell linages, MSCs exert unique pro-angiogenic, anti-inflammatory, and immuno-modulatory effects that promote tissue repair and regeneration. These characteristics of MSCs are attractive for their application in cell-based therapies for tissue regeneration.
Scientific RepoRts | 6:36120 | DOI: 10.1038/srep36120 vascular patency improves renal and cardiac function in porcine renovascular disease, confirming the safety and efficacy of this intervention [8] [9] [10] [11] . Accumulating data indicate that MSCs release large amounts of extracellular vesicles (EVs) that mediate their paracrine effects by shuttling different types of RNAs (e.g., mRNA and miRNA) and proteins to recipient cells 12, 13 . Consistent with this concept, we recently found that porcine MSC-derived EVs contain a selective combination of mRNAs and miRNAs capable of regulating transcription of genetic information and modulating angiogenesis, adipogenesis, and other pathways in recipient cells 14 . To support the potential utility of EVs in augmenting MSC-related therapies, the protein expression profile of porcine MSC-derived EVs needs to be characterized. In this study, we elucidated the protein content of porcine MSC-derived EVs to gain important insight into the molecular mechanisms by which they exert paracrine actions and contribute to the reparative potency of MSCs. Using a quantitative proteomic strategy to study the protein cargo of porcine MSC-derived EVs, we identified candidate proteins and biological signatures that are consistent with the postulated therapeutic effects of MSCs.
Materials and Methods
MSC and EV characterization and culture. All experiments were performed in accordance with the guidelines and approval of the Mayo Clinic Institutional Animal Care and Use Committee. MSCs were isolated from subcutaneous abdominal fat (5-10 g) of 3 female domestic pigs, as previously described 14 . Cells were cultured for 3 weeks in advanced MEM medium (Gibco/Invitrogen) supplemented with 5% platelet lysate (PLTmax, Mill Creek Life Sciences, Rochester, MN) in 37°/5% CO 2 , and the third passage collected for in vitro phenotypic and functional analyses. MSCs expressed CD44, CD90, and CD105 markers, and differentiated into osteocytes, chondrocytes, and adipocytes, as previously described 8, 9, 15 , consistent with our experience with human MSCs 16 . EVs were obtained from supernatants of MSCs using the ultra-centrifugation method 14 . In brief, 10 × 10 6
MSCs (a dose used for in vivo injections) [8] [9] [10] [11] were cultured for 48 h in advanced MEM medium without supplements and centrifuged at 2,000 g. Cell-free supernatants were then subjected to ultra-centrifugation at 100,000 g for 1 h at 4 °C, washed in serum-free medium containing HEPES 25 mM, and submitted to a second step of ultracentrifugation.
Transmission electron microscopy (TEM) of MSC supernatant with 2% uranyl acetate negative staining was performed, and cup-shaped 40-1000 nm structures identified as EVs. Micrographs were taken on a digital electron microscopy (JEOL 1200 EXII). EVs were further characterized based on the expression of EV (CD9, CD29, and CD63) and MSC (CD105 and CD73) surface markers by western blotting. In addition, EV size distribution was assessed by nanoparticle tracking analysis (NTA) using NanoSight NS300. EVs were diluted with PBS and samples continuously run through a flow-cell top-plate at 25 μ L/min. Three videos (120 seconds each) of Brownian motion of nanoparticles were recorded and 1,000 completed tracks analyzed using NTA 2.3.5.
Proteomic profiling and network pathway analysis. Liquid chromatography mass spectrometry (LC-MS/MS) proteomic analysis was performed at the Mayo Clinic Proteomics Core, as previously described 17, 18 . All MSC and EV pellets were solubilized in Tris buffer with 1%SDS HALT protease inhibitor and Benzonase. Lysis was achieved with by rapid agitation ('vortexing') followed by three consecutive 5 min incubations on ice. Protein samples were then denatured by incubation at 85 °C for 10 min. Aliquots with a protein equivalent of 20 μ g were dried down and resolubilized in reducing sample buffer. Samples were electrophoresed in 4-20% TGX Ready gels at 200 V for 30 min.
The gel lanes were divided into 6 evenly spaced horizontal regions using as guides protein bands that were common to all samples. Each sample lane was cut length-wise in the middle to obtain technical duplicates. The resulting individual gel sections were diced and transferred into PCR tubes for digestion and extraction. Gel sections were digested with trypsin following a previously described protocol 18 . In brief, each gel section was de-stained and the proteins present in the section were reduced with dithiothreitol and alkylated with iodoacetamide. Proteins were digested by overnight incubation at 37 °C with 140 ng of trypsin dissolved in 25 mM Tris (pH 8.2). Peptides were extracted from the gel piece with 30 μ L of 50% acetonitrile in 4% trifluoroacetic acid, followed by two additional extractions with 50 μ L aliquots of acetonitrile. The combined extracts were evaporated to dryness on a vacuum concentrator and stored at − 80 °C until further analysis.
Peptide extracts from each gel section were reconstituted in 40 μ L HPLC-grade water containing 0.2% formic acid, 0.1% trifluoroacetic acid, and 0.002% Zwittergent 3-16. Aliquots of the peptide extracts (typically 10 μ L, but 15 μ L for the two gel sections encompasses higher molecular weight proteins) were loaded onto a 0.25 μ L bed OptiPak trap (Optimize Technologies, Oregon City, Oregon) custom-packed with 5 μ m, 200 Å Magic C8 (Bruker-Michrom, Auburn, CA) in the stationary phase. The loaded trap was washed for 4 min with an aqueous loading buffer of 0.2% formic acid and 0.05% trifluoroacetic acid at a flow rate of 10 μ L/min. Following the wash, peptides were transferred via a 10-port valve onto a 35 cm × 100 μ m PicoFrit column 9 (NewObjective, Woburn, MA), self-packed with Agilent Poroshell 120S 2.7 μ m EC-C18 stationary phase, using a Dionex UltiMate 3000 RSLC LC system (Thermo-Fisher Scientific, Waltham, MA). Peptides were separated using a 400 nL/min LC gradient comprised of 2-30%B in 0-70 min, 30-50%B from 70-100 min, 50-95%B from 100-104 min, held at 95%B for 8 min and re-equilibrated to 2%B. Mobile phase A was 2% acetonitrile in water with 0.2% formic acid and mobile phase B was acetonitrile /isopropanol/water (80/10/10 by volume) with 0.2% formic acid. Eluting peptides were analyzed using a QExactive mass spectrometer (Thermo-Fisher Scientific, Waltham, MA). The instrument was operated in data-dependent mode by collecting MS1 data at 70,000 resolving power (measured at m/z 200) with an AGC value of 3E6 over an m/z range of 350-2000, using lock masses from background polysiloxanes at m/z 371.10123 and 445.12002. Precursors were fragmented with normalized collision energy of 27, and fragments measured at 17,500 resolving power and a fixed first mass of 140. Tandem mass spectra (MS/MS) were collected for the top 15 precursor masses present in each MS1 using an AGC value of 1E5, maximal ion fill time of 100 ms, an isolation window of 3.0 Da, isolation offset of 0.5 Da, and a dynamic exclusion time of 60 s.
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We utilized a label-free peptide MS1 intensity-based method for finding differentially expressed proteins between experimental groups. The quality of the raw data was assessed using the quality control metrics in the Swift proteomic data processing pipeline. MaxQuant (version 1.5.1) software processed the raw data files to produce a list of protein groups and their corresponding intensities in each sample 19 . To accomplish this, MaxQuant was configured to use a composite porcine protein sequence database containing UniProt porcine reference proteome (downloaded on 08/12/2015) and sequences of common contaminants (trypsin, keratin, cotton, wool, etc.). Reversed protein sequences were appended to the database for estimating protein identification false discovery rates (FDRs). The software was configured to use 20 ppm m/z tolerance for precursors and fragments while performing peptide-spectrum matching. The software derived semi-tryptic peptides from the sequence database while looking for the following variable modifications: carbamidomethylation of cysteine (+ 57.023 Da.), oxidation of methionine (+ 15.994 Da.), formation of n-terminal pyroglutamic acid (− 17.023 Da.) and protein n-terminal acetylation (+ 42.01 Da.). MaxQuant was instructed to align the runs and match features between multiple sample runs of the same gel region. The software filtered peptide and protein identifications at 1% FDR, assembled protein identifications into groups and reported protein group intensities.
An in-house R-programming script performed differential expression analysis using protein group intensities. First, protein group intensities of each sample were log 2 transformed and normalized using a trimmed mean (5%) method. For each protein group, the normalized intensities observed in two groups of samples were modeled using a Gaussian-linked generalized linear model. ANOVA was used to detect the differentially expressed protein groups between pairs of experimental groups. Differential expression analysis was performed after the data was normalized by protein loading, and differential p-values FDR-corrected using the Benjamini-Hochberg-Yekutieli procedure 20 . Protein groups with an FDR < 0.05 and an absolute fold change (EVs/MSCs) > 10 were classified as enriched in EVs, whereas those with FDR < 0.05 and fold change < − 10 were considered as excluded.
Proteins enriched in or excluded from EVs were classified by their molecular function, cellular localization, and class, using Protein Analysis Through Evolutionary Relationships (PANTHER) 21 . Functional pathway analysis was performed using the Database for Annotation and Integrated Discovery (DAVID 6.7) 22 .
Validation of proteomic analysis. Complement component (C2), vascular endothelial growth factor
(VEGF), and von Willebrand factor (vWF) proteins, which were all enriched in EVs, were selected for validation, and their expression in EVs and MSCs measured by Western blot (Novus: Cat#NBP1-58985, Santa Cruz Biotech: cat# sc-152, and Abcam: cat#ab6994, respectively). Similarly, we validated the expression of RNA polymerase-associated protein RTF1 homolog (RTF1) and FOS-Like Antigen 1 (FOSL1) excluded from EVs (Abcam: cat#ab99362 and LifeSpan BioSiences, Inc. cat#:aa130-179, respectively).
Results
Cultured MSCs released significant amounts of EVs with a classic "cup-like" morphology (Fig. 1A) , most of which were under 300 nm in size with a bi-phasic size-distribution (Fig. 1B) consistent with a composition of approximately 2/3 small microvesicles (~125 nm) and 1/3 exosomes (~55 nm). The EV expressed primarily EV (CD9, CD29, and CD63) and MSC surface markers (CD105 and CD73) (Fig. 1C ).
Identification and classification of differentially expressed proteins. Proteomics analysis identified
peptides derived from a total of 5,469 distinct protein groups in MSCs and 4,937 in EVs, with molecular weights ranging from 10-250 kDa ( Fig. 2A) . Average protein expression was higher in MSCs compared to EVs (Fig. 2B , p < 0.0001). EVs expressed 12 MSC and 77 EV markers (Tables 1 and 2 ). Differential expression analysis revealed 128 proteins upregulated in EVs vs. MSCs (Table S1 , fold change EVs/MSCs > 10, p < 0.05), whereas 573 proteins were excluded from EVs (fold change EVs/MSCs < − 10, p < 0.05) (Fig. 2C ).
Proteins enriched in EVs. The majority of the proteins enriched in EVs showed binding, catalytic, and receptor activity, and were equally distributed between intracellular and extracellular compartment categories (Fig. 3A,B) . A number of different classes of proteins were enriched in EVs, with receptors, signaling molecules, and enzyme modulators representing the most frequently occurring protein categories types (Fig. 3C) . Functional classification showed a remarkable diversity of biological roles. A total of 52 clusters were identified, among which glycoproteins, extracellular space, and signaling proteins comprised the most relevant category (enrichment score = 15.4). From a biological perspective, these proteins are functionally involved in angiogenesis, blood coagulation, extracellular matrix remodeling, inflammatory response, and apoptosis (Fig. 4) . These main categories were followed by closely related categories that encompass proteins involved in wound healing (enrichment score = 8.04), extracellular matrix (5.03), and adaptive immune response (4.46). The remaining categories were approximately equally distributed (average enrichment score = 1.2 ± 0.8).
Proteins excluded from EVs. Proteins excluded from EVs possessed binding and catalytic activity, and were mostly detected in key cell functions and organelles (Fig. 5A,B) . The major functional class for these excluded proteins was the nucleic acid binding proteins, followed by transcription factors and enzyme modulators (Fig. 5C ). Functional pathway analysis revealed their participation in a broad spectrum of cellular processes and subcellular locations (56 clusters). The most notable categories are nuclear proteins (enrichment score = 10.08), nucleoplasm (5.78), RNA splicing (4.9), nucleotide binding (4.67), and nucleolus (4.21) (Fig. 6A) . The remaining 51 categories were equally distributed (average enrichment score = 0.7 ± 0.5).
Validation of proteomic analysis. Expression of the candidate proteins followed the same patterns as the proteomics findings. Specifically, C2, VEGF, and vWF were higher in EVs compared to their parent MSCs, whereas RTF1 and FOSL1 were higher in MSCs (Fig. 6B) .
Discussion
In the current study, we describe the biological signature of porcine MSC-derived EVs from a proteomics perspective. Our analysis identified a large number of proteins enriched in EVs, bearing the potential to act as modulators of angiogenesis, blood coagulation, extracellular matrix remodeling, apoptosis, and inflammation. Moroever, we identified several nuclear proteins and proteins involved in nucleotide binding and RNA splicing that are selectively excluded from EVs. These observations provide important insights into the molecular mechanisms underpinning the reparative capacity of MSC-derived EVs and underscore the broad spectrum of factors present in EVs as mediators of MSC-related intercellular communication. Moreover, our findings might help develop novel regenerative therapies using MSC-derived EVs for tissue repair.
Accumulating evidence indicates that EVs are major effectors of the paracrine actions of MSCs, and mediate their cell-to-cell comunication. Bruno and colleagues demonstrated that EVs derived from human bone marrow MSCs stimulate proliferation in vitro and confer resistance to apoptosis in renal tubular epithelial cells by activating a proliferative program via horizontal transfer of mRNA 23 . MSC-derived EVs have also been shown to reduce infarct size in mice with myocardial ischemia/reperfusion injury 24 and promote angiogenesis in rats with myocardial infarction 25 . These results clearly indicate that EVs contribute to the principal trophic effects of MSC transplantation.
We have recently characterized the mRNA and miRNA cargo of porcine MSC-derived EVs using high-throughput RNA sequencing analysis to elucidate nucleic acid-based mechanisms by which they exert their tissue protective properties 14 . We found that MSC-derived EVs contain a combination of mRNAs and miRNAs capable of regulating transcription of genetic information and modulating angiogenesis, adipogenesis, extracellular matrix turnover, TGF-β signaling, and other pathways in recipient cells. The current study extends our previous observations and demonstrates that MSC-derived EVs contain proteins capable of modulating several signaling pathways and gene networks, providing molecular evidence useful to elucidate the paracrine effects of MSCs. Of particular interest for the use of EVs in supporting cardiovascular repair, our current proteomic findings combined with our previous transcriptomic findings indicate that EVs are enriched for proteins, mRNAs and miRNAs that individually, and perhaps together, support angiogenesis.
LC-MS/MS analysis offers the possibility to quantitatively characterize multiple protein groups by combining the physical separation capabilities of LC with the mass analysis capabilities of MS. Our proteomic analysis show that EVs derived from porcine adipose tissue MSC express several prototypical MSC markers (e.g. CD44, CD73, and CD105), as well as 79 of the top 100 EV markers identified in the Exocarta database (http://www.exocarta. org/, e.g. CD29 and CD63). Notably, we identified 128 proteins enriched in EVs compared to MSCs. Funtional enrichment analysis of these proteins indicates high representation of glycoprotein, extracelular space, and signaling proteins involved in angiogeneis, inflammation, matrix remodeling, blood coagulation, and apoptosis.
Experimental studies have demonstrated the pro-angiogenic potential of MSCs both in vivo and in vitro, providing a mechanistic rationale for their therapeutic use in stimulating angiogenesis. We have previously shown that a single intra-renal delivery of MSC substantialy improved the porcine renal microvasculature, associated with increased renal expression of VEGF, a key angiogenic factor that promotes endothelial cell survival and vascular sprouting 8 . The current study shows that VEGF is enriched in EVs, associated with upregulation of Ephrin-B2, a transmembrane ligand for Eph receptor tyrosine kinases that promotes VEGF-induced angiogesis 26 . Therefore, EVs may not only deliver the VEGF protein, but also upregulate its production in recipient cells. Furthermore, the EV proteome also includes several other key proteins involved in angiogenesis, such as angiopoietin-related protein-4, platelet-derived growth factor-C (PDGFC), and Wingless-Type (wnt) MMTV Integration Site Family, Member 7B (WNT7B). Our observations are underscored by recent findings showing up-regulated angiogenic associated pathways in exosomes derived from human bone marrow MSCs 27 , illustrating the conservation of the nature of EV cargo across species. Indeed, using a Venn diagram analysis, we compared UniProt ID Gene Name UniProt ID Gene Name UniProt ID Gene Name F1RRD6_PIG  PDCD6IP  I7HD36_PIG  ATP1A1  K9IVR9_PIG  KPNB1   G3P_PIG  GAPDH  F1SA98_PIG  YWHAQ  F1SB42_PIG  EZR   F1S073_PIG  ANXA2  FLOT1_PIG  FLOT1  F1SLC4_PIG  ANXA4   K7GST0_PIG  CD63  A0A0B8RSX6_PIG  FLNA  A0A0B8RW53_PIG  ACLY   F1RT83_PIG  SDCBP  A0A0B8S0A2_PIG  CLIC1  F2Z5N8_PIG  RAB14   A0A0B8RSY9_PIG  ENO1  CDC42_PIG  CDC42  A0A0B8RZJ8_PIG  GNB1   HS90A_PIG  HSP90AA1  D0G0C8_PIG  CCT2  A0A0B8RZ10_PIG  UBA1   A0A0B8S031_PIG  PKM  K9J6H8_PIG  A2M  F1SS26_PIG  THBS1   LDHA_PIG  LDHA  F2Z4Z1_PIG  YWHAG  F1RFQ7_PIG  RAN   F2Z558_PIG  YWHAZ  I3LFI0_PIG  RAC1  RAB5A_PIG  RAB5A   PGK1_PIG  PGK1  M3V7× 9_PIG  LGALS3BP  F1SAY0_PIG  PTGFRN   I3LII3_PIG  EEF2  Q06AS6_PIG  GNAI2  I3LR32_PIG  CCT5   F2Z5C1_PIG  ANXA5  ANXA1_PIG  ANXA1  TCPG_PIG  CCT3   I3LC73_PIG  FASN  I3LVS7_PIG  RHOA  B0LY42_PIG  BSG   C0MHR2_PIG  CLTC  B2CZF8_PIG  MFGE8  SAHH_PIG  AHCY   Q007T3_PIG  CD81  F1SDX9_PIG  PRDX2  I3LFZ8_PIG  RAB5B   F1RUN2_PIG  ALB  F1RUK8_PIG  GDI2  I3LLG9_PIG  LAMP2   D0G7F6_PIG  TPI1  F1SSX0_PIG  EHD4  I3LEE5_PIG  ITGA6   F2Q9A3_PIG  PPIA  F1RI39_PIG  ACTN4  GELS_PIG  GSN   F1RTN3_PIG  MSN  F1SDR7_PIG  YWHAB  F1SS24_PIG  FN1   COF1_PIG  CFL1  F1SPG0_PIG  RAB7A  F2Z4Y1_PIG  YWHAH   F1S3U9_PIG  PRDX1  A5GFU2_PIG  GNAS  F1SR80_PIG  TUBA1A   F1RFY1_PIG  PFN1  D7RK08_PIG  TFRC  A8U4R4_PIG  TKT   F1RVE7_PIG  ITGB1  F2Z560_PIG  RAB5C  F1SB63_PIG  TCP1   F1RS36_PIG  HSPA5  M3VH45_PIG  ANXA6  F2Z5I8_PIG  RAB8A   I3LB80_PIG  SLC3A2  F1S2E2_PIG  ANXA11   Table 2 . EV markers expressed in EVs.
our findings with those reported by Anderson et al., and identified 1,362 common EV proteins, among which several are involved in vascular development and angiogenesis including angiopoietin-1, Wnt Family Member-5A, and Notch-1 ( Figure S1 ). Overall, there incomplete (~70%) overlap of EV proteins between the studies may be due to differences in MSC origin, interspecies variability, culture medium, and EV isolation methods. Importantly, our study extends previous findings, as our LC-MS/MS analysis identified a larger number of EV proteins. MSCs also possess potent immunosuppressive and anti-inflammatory properties, partly via non-specific anti-proliferative actions on a wide range of immune cells 28 . Interestingly, we found increased EV expression of several inflammatory mediators, particularly members of the complement system, which modulate adaptive immune responses by interacting with receptors on dendritic cells and lymphocytes 29 . Furthermore, the complement system mediates the migration of MSCs to sites of inflammation and tissue injury, enhancing its immuno-modulatory actions 30 . Additionally, proteins involved in extracellular matrix remodeling were enriched in EVs compared to MSCs. These included matrix metalloproteinase 9 (MMP9), which is involved in the breakdown of extracellular matrix, but also secreted by MSC and downregulates the cytotoxicity of natural killer cells 31, 32 . Thus, delivery of this enzyme in EVs may supplement MSC immuno-modulatory actions. Furthermore, TGF-β 1 is enriched in EVs. We have previously shown that EVs contain high levels of several mRNAs that encode for protein ligands within . TGFβ proteins are involved in tissue remodeling and fibrosis, but also induce CD4+ /CD25+ regulatory T-cells, dampering the inflammatory response 33 . In addition, TGFβ induces release of cytochrome-c from mitochondria triggering apoptosis 34 . Interestingly, we observed upregulation in other proteins that modulate apoptosis, including netrin-1 and secreted frizzled-related protein (SFRP)-5 35, 36 . These observations may therefore indicate a pro-apoptotic function for EVs, possibly to facilitate removal of damaged cells.
We also found robust EV expression of proteins involved in blood coagulation, such as vWF, coagulation factor X, and plasma kallikrein, which may reflect the innate procoagulant activity of MSCs. Consistent with this concept, a recent study showed that intracoronary MSC delivered during reperfusion in porcine may manifest pro-coagulant properties, emphasizing the need for caution when applying cell-based therapy 37 . Interestingly, our EVs express several members of the secretory component of platelets, including vWF, PDGFC, and TGFβ , possibly because MSCs were cultured in platelet lysate 38 . However, our MSCs do not express endothelial markers like CD31 and CD34 8, 9 , arguing against contamination with endothelial cells. Further studies are needed to explore the mechanisms by which vWF is enriched in MSC-derived EVs.
Apart from enrichment, our results revealed selective exclusion of a number of proteins from EVs, such as nuclear proteins and proteins involved in nucleotide binding and RNA splicing, including nucleolar complex associated-4 homolog, cleavage and polyadenylation specific factor-3, and CWC15 spliceosome-associated protein homolog. The mechanisms that regulate packaging these molecules into EVs remain unclear, but evidently cells are definitely selective in determining what proteins emerge as cargo in EVs.
Our study is limited by the relatively low number of samples, given the labor and cost of obtaining EVs from porcine disease models and of proteomic analysis. Nevertheless, a similar number of samples is commonly used in comparable studies reporting cell/tissue proteomic profiles 39, 40 . Furthermore, post-translational changes in MSCs and EVs proteins unrevealed by proteomic analysis were not be assessed here, although LC-MS/MS has high sensitivity and robust precision for detecting MSC and EV protein groups. Indeed, follow-up studies using western blots demonstrated the efficacy of our proteomic analysis to detect changes in representative protein expression between MSCs and the EVs they produce. Future studies are needed to confirm these findings and test whether the protein content of in-vivo MSCs correlates with our observations in cultured MSCs. In addition, additional studies may ascribe specific cargo in our EV to microvesicles versus exosomes.
In summary, having examined the proteome of porcine MSCs and EVs, this study identified a number of proteins that may contribute to the molecular mechanisms involved in MSC-mediated tissue repair. We identified 
